# Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

> **NCT06953622** · — · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 330 (estimated)

## Conditions studied

- Migraine
- Patent Foramen Ovale

## Interventions

- **DRUG:** Conservative treatment
- **DRUG:** Antipaletet drug
- **PROCEDURE:** Patent Foramen Ovale Closure

## Key facts

- **NCT ID:** NCT06953622
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953622, "Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06953622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*